Trial Profile
Phase III study of KW-6485P for pediatric patients with symptomatic or cryptogenic localization-related epilepsy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2020
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin; Kyowa Kirin
- 01 Jun 2016 New trial record